StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.98−0.04 (-3.43%)

Close on Oct 19, 2026Market cap $4.95MP/E –Yield –

Imunon gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Imunon

Imunon has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Imunon figures

See a number that looks wrong?